rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
1998-8-31
|
pubmed:abstractText |
To determine, in women with primary operable breast cancer, if preoperative doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan; AC) therapy yields a better outcome than postoperative AC therapy, if a relationship exists between outcome and tumor response to preoperative chemotherapy, and if such therapy results in the performance of more lumpectomies.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0732-183X
|
pubmed:author |
pubmed-author:BegovicMM,
pubmed-author:BrownAA,
pubmed-author:BryantJJ,
pubmed-author:CHINJ HJH,
pubmed-author:DeCillisAA,
pubmed-author:DimitrovN VNV,
pubmed-author:FELDHH,
pubmed-author:FisherBB,
pubmed-author:FisherE RER,
pubmed-author:HoehnJ LJL,
pubmed-author:LeesA WAW,
pubmed-author:MamounasEE,
pubmed-author:MargoleseR GRG,
pubmed-author:RobidouxAA,
pubmed-author:WickerhamD LDL,
pubmed-author:WolmarkNN
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2672-85
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9704717-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9704717-Breast Neoplasms,
pubmed-meshheading:9704717-Combined Modality Therapy,
pubmed-meshheading:9704717-Cyclophosphamide,
pubmed-meshheading:9704717-Disease-Free Survival,
pubmed-meshheading:9704717-Doxorubicin,
pubmed-meshheading:9704717-Female,
pubmed-meshheading:9704717-Humans,
pubmed-meshheading:9704717-Middle Aged,
pubmed-meshheading:9704717-Prognosis,
pubmed-meshheading:9704717-Proportional Hazards Models,
pubmed-meshheading:9704717-Survival Rate
|
pubmed:year |
1998
|
pubmed:articleTitle |
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
|
pubmed:affiliation |
National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Centers, Pittsburgh, PA, USA. bfisher@aherf.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|